TabletsClinical Overview
Aripiprazole is a third-generation quinolinone atypical antipsychotic functioning as a dopamine-serotonin system stabilizer. It acts as a partial agonist at dopamine D2 and D3 receptors and serotonin 5-HT1A receptors, and an antagonist at 5-HT2A receptors. By acting as a partial agonist, it buffers hyperactive dopamine in mesolimbic circuits (alleviating positive symptoms) while supporting dopamine activity in mesocortical circuits (improving negative symptoms and avoiding parkinsonism and hyperprolactinemia). Indicated for schizophrenia, acute manic/mixed bipolar episodes, adjunctive treatment in major depression, and Tourette's disorder.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally once daily, in the morning or evening with a glass of water, with or without meals. Maintain consistent dosing. Taper gradually before stopping.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Akathisia (inner motor restlessness), nausea, vomiting, headache, insomnia, somnolence, lightheadedness. Rare/Severe: Boxed warning: Mortality in elderly dementia patients and suicidality in young patients; impulse-control disorders (pathological gambling, compulsive eating/shopping/sex), NMS, and tardive dyskinesia.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Boxed warnings for dementia psychosis mortality and antidepressant suicidality. Specific warning for impulse-control problems (compulsive gambling, shopping); advise patients and families to monitor for sudden behavioral changes. Akathisia is common during dose titration.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Aripiprazole Tablets 5mg
Aripiprazole is a third-generation quinolinone atypical antipsychotic functioning as a dopamine-serotonin system stabilizer. It acts as a partial agonist at dopamine D2 and D3 receptors and serotonin 5-HT1A receptors, and an antagonist at 5-HT2A receptors. By acting as a partial agonist, it buffers hyperactive dopamine in mesolimbic circuits (alleviating positive symptoms) while supporting dopamine activity in mesocortical circuits (improving negative symptoms and avoiding parkinsonism and hyperprolactinemia). Indicated for schizophrenia, acute manic/mixed bipolar episodes, adjunctive treatment in major depression, and Tourette's disorder.
Aripiprazole Tablets 2.5 mg
Aripiprazole is a third-generation quinolinone atypical antipsychotic functioning as a dopamine-serotonin system stabilizer. It acts as a partial agonist at dopamine D2 and D3 receptors and serotonin 5-HT1A receptors, and an antagonist at 5-HT2A receptors. By acting as a partial agonist, it buffers hyperactive dopamine in mesolimbic circuits (alleviating positive symptoms) while supporting dopamine activity in mesocortical circuits (improving negative symptoms and avoiding parkinsonism and hyperprolactinemia). Indicated for schizophrenia, acute manic/mixed bipolar episodes, adjunctive treatment in major depression, and Tourette's disorder.
Aripiprazole Tablets 15 mg
Aripiprazole is a third-generation quinolinone atypical antipsychotic functioning as a dopamine-serotonin system stabilizer. It acts as a partial agonist at dopamine D2 and D3 receptors and serotonin 5-HT1A receptors, and an antagonist at 5-HT2A receptors. By acting as a partial agonist, it buffers hyperactive dopamine in mesolimbic circuits (alleviating positive symptoms) while supporting dopamine activity in mesocortical circuits (improving negative symptoms and avoiding parkinsonism and hyperprolactinemia). Indicated for schizophrenia, acute manic/mixed bipolar episodes, adjunctive treatment in major depression, and Tourette's disorder.
Aripiprazole Tablets 20 mg
Aripiprazole is a third-generation quinolinone atypical antipsychotic functioning as a dopamine-serotonin system stabilizer. It acts as a partial agonist at dopamine D2 and D3 receptors and serotonin 5-HT1A receptors, and an antagonist at 5-HT2A receptors. By acting as a partial agonist, it buffers hyperactive dopamine in mesolimbic circuits (alleviating positive symptoms) while supporting dopamine activity in mesocortical circuits (improving negative symptoms and avoiding parkinsonism and hyperprolactinemia). Indicated for schizophrenia, acute manic/mixed bipolar episodes, adjunctive treatment in major depression, and Tourette's disorder.